Communications in Early Detection and Intervention Programs: Legal and Risk Management Perspectives[*]

Abstract

Since the introduction of newborn screening, public health policy making has addressed the twin goals of providing organized preventive health care and achieving universal access to these services. Simultaneously, consumer rights movements have led to the expectation that medical rights will be understood and respected whether a test or treatment is voluntary or mandatory. Although universal identification and intervention programs have become feasible with the development of reliable screening methods, the transition from screening to follow-up presents challenges. To ensure timely followup while balancing social goals with individual rights, effective clinical communication is essential. Legal and risk management considerations surrounding informed consent, notification of results, and confidentiality assist the clinician in developing policy and procedural guidelines for quality assurance in this crucial area.

Key Words:

Newborn hearing screening - risk management - clinical communication

The information contained in this publication is not legal advice. For information regarding regulations and policies as they apply to specific situations, please consult an attorney.

The information contained in this publication is not legal advice. For information regarding regulations and policies as they apply to specific situations, please consult an attorney.